ClinicalMetric / Countries / Greece / hospital acquired pneumonia
← 🇬🇷 Greece Trials
🇬🇷 Greece Country × Condition

hospital acquired pneumonia Clinical Trials in Greece

Active clinical trials for hospital acquired pneumonia with research sites in Greece. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇬🇷 Greece

Active Trials in Greece (1)

NCT06269900 Phase 3
Recruiting

Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype

Enrollment
450 pts
Country
🇬🇷 Greece
Nantes University Hospital
View Trial →

Frequently Asked Questions

How many hospital acquired pneumonia clinical trials are active in Greece?
There are currently 1 active clinical trials for hospital acquired pneumonia with sites in Greece, of which 1 are actively recruiting patients.
How can I join a hospital acquired pneumonia clinical trial in Greece?
To join a hospital acquired pneumonia clinical trial in Greece, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Greece directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hospital acquired pneumonia trials in Greece?
Active hospital acquired pneumonia trials in Greece span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Greece Trials → Global hospital acquired pneumonia Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology